Radiopharmaceuticals
Ended Awarded Last action
- Contract number
- HT009026FG0110044
- Awardee
-
Sun Pharmaceutical Industries, Inc. UEI CN7NRYVDXEA7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $19,003
Award facts
- Contract value 100% obligated
- $19,003.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Princeton, NJ, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $19,003.20 firm fixed-price blanket purchase agreement (BPA) call for radiopharmaceuticals to Sun Pharmaceutical Industries, Inc. on January 8, 2026, with completion targeted for September 30, 2026. This contract represents a non-set-aside procurement and will be performed at the contractor's facility in Princeton, New Jersey. Sun Pharmaceutical Industries, Inc. specializes in manufacturing radiopharmaceutical products for medical imaging and nuclear medicine applications, serving as a critical supplier to federal healthcare agencies.
This award is issued under Sun Pharmaceutical Industries, Inc.'s existing Federal Supply Schedule contract (valued at $117.4 million through June 2026) under the Pharmaceuticals and Drugs schedule, which provides an indefinite-delivery vehicle for the Department of Veterans Affairs and Defense Health Agency. The company's product portfolio includes radiopharmaceutical isotopes, radiotracers, syringes, and shields used in diagnostic imaging for myocardial infarction, gallbladder disorders, and breast cancer evaluation. This BPA call enables efficient procurement of specialized nuclear medicine products across military treatment facilities and VA medical centers, supporting the Defense Health Agency's mission to maintain critical medical diagnostic capabilities.
Quick answers
Who was awarded contract HT009026FG0110044?
HT009026FG0110044 was awarded to Sun Pharmaceutical Industries, Inc. by Defense Health Agency (Department of Defense) on January 8, 2026.
How much is contract HT009026FG0110044 worth?
The government has obligated $19,003 on HT009026FG0110044.
Is contract HT009026FG0110044 an order under another contract?
Yes. HT009026FG0110044 is a BPA call under HT001425A0012, a blanket purchase agreement.
Was contract HT009026FG0110044 competed?
The extent of competition for HT009026FG0110044 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award